On the 10th anniversary of a project that redefined the landscape of Kendall Square, developer Alexandria Real Estate Equities is gearing up to transform yet another area into a mecca for the biotech industry.
It was 10 years ago last month that Alexandria (NYSE: ARE) bought the seven buildings that make up Technology Square, the biggest contiguous campus development in the company’s largest region in the country, for $600 million from the Massachusetts Institute of Technology. The 1.2-million-square-foot area — which represents about a fifth of the company’s total Boston-area properties — has become home to research facilities for biotechs like Epizyme and Moderna, playing a major role in the areas transformation into the early-stage biotech hub of the world.
Image: The One Kendall Square courtyard. ALEXANDRIA - http://www.bizjournals.com
